Intravenous Immunoglobulin in the Treatment of Severe Clostridium Difficile Colitis

Intravenous immunoglobulin (IVIG) has been utilized in patients with recurrent and refractory Clostridium difficile colitis. It is increasingly being used in patients with initial clinical presentation of severe colitis. Herein, we report a case of severe C. Difficile colitis successfully treated with IVIG with a review of the medical literature to identify the optimal timing and clinical characteristics for this treatment strategy.

[1]  D. Pardi,et al.  Clostridium difficile infection: new insights into management. , 2012, Mayo Clinic proceedings.

[2]  T. Chandrasekar,et al.  Intravenous immunoglobulin therapy for refractory Clostridium difficile toxin colitis in chronic kidney disease: case reports and literature review , 2007, NDT plus.

[3]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  A. Hassoun,et al.  Use of intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis. , 2007, The American journal of geriatric pharmacotherapy.

[5]  R. Branch,et al.  Clinical outcomes of intravenous immune globulin in severe clostridium difficile-associated diarrhea. , 2007, American journal of infection control.

[6]  C. Rees,et al.  Intravenous Immunoglobulin for the Treatment of Severe, Refractory, and Recurrent Clostridium difficile Diarrhea , 2006, Diseases of the colon and rectum.

[7]  C. Kelly,et al.  Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. , 2000, The New England journal of medicine.

[8]  J. Kink,et al.  Antibodies to Recombinant Clostridium difficile Toxins A and B Are an Effective Treatment and Prevent Relapse of C. difficile-Associated Disease in a Hamster Model of Infection , 1998, Infection and Immunity.

[9]  C. Pothoulakis,et al.  Intravenous immunoglobulin therapy for severe Clostridium difficile colitis , 1997, Gut.

[10]  B. Jaar,et al.  Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature. , 2010, Journal of hospital medicine.